Microbot Medical Inc. (Nasdaq: MBOT), a developer of the innovative LIBERTY Endovascular Robotic System, announced its participation in the Roth Annual Growth Conference scheduled for March 22-24, 2026, in Laguna Niguel, California. Harel Gadot, the CEO, President, and Chairman of the company, will present live during a fireside Q&A discussion on March 23, 2026, at 4:00 PM PT. This event is significant as it comes just ahead of the full market release of the LIBERTY system, which is expected in April 2026. The conference is a premier event that connects growth companies with institutional investors and industry leaders, providing a platform for presentations, panel discussions, and one-on-one meetings. The company has indicated that the ongoing progress and success of its limited market release has validated its strategy for the upcoming full market launch. Investors can access the live webcast of the presentation through the 'Events' section of Microbot Medical's website. Additionally, updated presentation materials will be available under the 'Investors' section of the website. This participation is expected to enhance the company's visibility and support its growth trajectory in the medical device sector.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.